PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 86 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q1 2014. The put-call ratio across all filers is 1.41 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,000,439 | -53.9% | 119,813 | -26.5% | 0.07% | -52.8% |
| Q2 2023 | $2,168,219 | +224.6% | 163,024 | +7.8% | 0.14% | +132.8% |
| Q2 2022 | $668,000 | +105.5% | 151,259 | +322.6% | 0.06% | +117.9% |
| Q1 2022 | $325,000 | +577.1% | 35,793 | +1405.2% | 0.03% | +600.0% |
| Q4 2021 | $48,000 | -96.9% | 2,378 | -96.1% | 0.00% | -96.5% |
| Q3 2021 | $1,569,000 | +9.6% | 61,410 | +49.9% | 0.12% | +1.8% |
| Q2 2021 | $1,432,000 | +12918.2% | 40,963 | +1762.0% | 0.11% | +11200.0% |
| Q3 2018 | $11,000 | – | 2,200 | +2100.0% | 0.00% | – |
| Q4 2017 | $0 | -100.0% | 100 | -98.4% | 0.00% | -100.0% |
| Q1 2016 | $52,000 | +5100.0% | 6,211 | +2288.8% | 0.01% | – |
| Q2 2015 | $1,000 | -96.9% | 260 | -93.7% | 0.00% | -100.0% |
| Q4 2014 | $32,000 | -11.1% | 4,097 | -45.0% | 0.01% | +100.0% |
| Q3 2014 | $36,000 | +1700.0% | 7,447 | +1761.8% | 0.01% | – |
| Q1 2014 | $2,000 | – | 400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Madrone Advisors, LLC | 16,415,933 | $137,073,041 | 29.47% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,638,395 | $13,680,598 | 4.20% |
| Decheng Capital Management III (Cayman), LLC | 1,463,872 | $12,223,331 | 4.08% |
| VK Services, LLC | 2,632,784 | $21,983,746 | 2.93% |
| Iron Triangle Partners LP | 1,800,000 | $15,030,000 | 2.20% |
| BOURNE LENT ASSET MANAGEMENT INC | 574,350 | $4,795,822 | 2.11% |
| Deep Track Capital, LP | 6,000,000 | $50,100,000 | 1.93% |
| Jackson Square Partners, LLC | 6,933,865 | $57,897,773 | 1.93% |
| ARK Investment Management | 29,822,440 | $249,017,370 | 1.90% |
| Nikko Asset Management Americas, Inc. | 13,447,666 | $112,153,534 | 1.34% |